Ketek Act I: FDA Updates Label, Touts Process On Eve Of Hearing
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency says it has “learned” from controversy surrounding the antibiotic, but FDA will likely still face congressional grilling about its actions.